Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (<scp>MelCOR</scp>): A modified Delphi study — Dale Jobson (2022) | RDL Network
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (<scp>MelCOR</scp>): A modified Delphi study
Article 2022 en
Authors
DJ
Dale Jobson
BR
Benjamin Roffey
CA
Christopher Arnold
Abstract
1 min read
This study provides a multi-stakeholder consensus for important clinical quality indicators that define optimal practice that will now be used in the Australian Melanoma Clinical Outcomes Registry (MelCOR).
Xiaoxuan Liu, Samantha Cruz Rivera, David Moher, Melanie Calvert, Alastair K. Denniston, Hutan Ashrafian, Andrew L. Beam, An-Wen Chan, Gary S. Collins, Ara DarziJonathan J Deeks, M. Khair ElZarrad, Cyrus Espinoza, Andre Esteva, Livia Faes, Lavinia Ferrante di Ruffano, John Fletcher, Robert Golub, Hugh Harvey, Charlotte Haug, Christopher Holmes, Adrian Jonas, Pearse A. Keane, ,
Xiaoxuan Liu, Samantha Cruz Rivera, David Moher, Melanie Calvert, Alastair K. Denniston, Ara Darzi, Christopher Holmes, Hutan Ashrafian, Jonathan J Deeks, Lavinia Ferrante di Ruffano, Livia Faes, Pearse A. Keane, Sebastian J. Vollmer, Aaron Lee, Adrian Jonas, Andre Esteva, Andrew L. Beam, Maria Beatrice Panico, Cecilia S. Lee, Charlotte Haug, Christopher Kelly, Cynthia D. Mulrow, ,
Discussion(0)
No comments yet. Be the first to comment.